Table 1.
Partial list of current and potential targets for cancer vaccine therapy
| Carcinoma-associated antigens | Endogenous Retroviral gene products | Leukemia/lymphoma antigens | Melanoma antigens | Viral antigens |
|---|---|---|---|---|
| Brachyury | HERV-H | Aberrant class II | MAGE | HPV |
| CA125 | HERV-K | Anti-idiotype | MART | |
| CEA | B1 | gp100 | ||
| EGFR | CD19 | Tyrosinase | ||
| HER-2/neu | CD20 | CD2 | ||
| KSA | CD22 | CD3 | ||
| Mesothelin | CD25 | GM2 | ||
| MUC-1 | CD36 | |||
| NY-ESO | ||||
| p53 | ||||
| PAGE-4 | ||||
| PAP | ||||
| PSA | ||||
| PSCA | ||||
| PSMA | ||||
| Ras | ||||
| sTn | ||||
| TARP | ||||
| VEGF |